
A new protein responsible for melanoma metastasis has been discovered by scientists.
The study showed that silencing the expression of protein called RAB27A resulted in reduced metastasis -- the process by which cancer spreads to other areas of the body -- which is the primary cause of death in melanoma patients.
Advertisement
‘RAB27A is a novel prognostic factor which means it could provide clinicians with a new way to determine a melanoma patient's future health outcome.’
Tweet it Now
While there have been recent advances in targeted and immune-based treatments, advanced stage melanoma remains a clinical challenge with a particularly poor prognosis, suggests the study published in the International Journal of Cancer.
"We also believe it could provide a brand new therapeutic target for the prevention of metastasis, which would improve the efficacy of future treatments", Guo added.
According to the researchers, Australia and New Zealand have the highest rates of melanoma in the world. More than 14,000 new cases of melanoma are estimated to have occurred in 2018.
Melanoma occurs when the pigment-producing cells that give colour to the skin become cancerous. The symptoms might include a new, unusual growth or a change in an existing mole. It can occur anywhere on the body.
Source: IANS
Advertisement
According to the researchers, Australia and New Zealand have the highest rates of melanoma in the world. More than 14,000 new cases of melanoma are estimated to have occurred in 2018.
Melanoma occurs when the pigment-producing cells that give colour to the skin become cancerous. The symptoms might include a new, unusual growth or a change in an existing mole. It can occur anywhere on the body.
Source: IANS
Advertisement
Advertisement
|
Advertisement
Recommended Readings
Latest Cancer News

The combination of the personalized cancer vaccine with ACT led to ovarian cancer control in few patients within a span of three months, stated study results.

Uncovering key kinases in tumor growth and invasion is crucial for improving targeted therapies in advanced-stage colorectal cancer.

The study findings validate metal-enhanced photo-oxidation for future metal-based anticancer drugs.

Mutations in 11 genes are linked to aggressive forms of prostate cancer, which may present novel therapeutic and therapy options.

Improved oral health, as indicated by the count of natural teeth and dental appointments preceding the diagnosis, correlated with enhanced head and neck cancer survival rates.